ConductScience.org, home

Paper3691598

A modified pharmacokinetic model for platinum disposition in ovarian cancer patients receiving cisplatin.

Griffiths H and 2 others. Eur J Clin Pharmacol, 1987. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. A modified pharmacokinetic model for platinum disposition in ovarian cancer patients receiving cisplatin. Papers, record 3691598. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3691598

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A modified pharmacokinetic model for platinum disposition in ovarian cancer patients receiving cisplatin.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.27
iCite
Revised in PubMed
2026-10-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Griffiths HH
2Shelley MDM D
3Fish RGR G

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
Ovarian NeoplasmsMajor topic
PlatinumMajor topic
Female
Humans
Kidney
Metabolic Clearance Rate
Middle Aged
Models, Biological
Protein Binding

Source PubMed

Download CSV of topics

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
27196063Potential effects of edema on the pharmacokinetics of platinum in patients treated with cis-dichlorodiammine platinum (II).Res Commun Chem Pathol Pharmacol1980https://conductscience.org/library/papers/7196063PubMed
37194166Clinical kinetics on intact cisplatin and some related species.Clin Pharmacol Ther1981https://conductscience.org/library/papers/7194166PubMed
46538459Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.Cancer Treat Rep1984https://conductscience.org/library/papers/6538459PubMed
56539967Total body clearance and platinum accumulation in patients treated with cis-dichlorodiammine platinum (II)Ther Drug Monit1984https://conductscience.org/library/papers/6539967PubMed
692179Acute phase reactant proteins in cancer.Adv Cancer Res1979https://conductscience.org/library/papers/92179PubMed
76468475Problems and pitfalls in estimating average pharmacokinetic parameters.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6468475PubMed
86161715Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/6161715PubMed
96891625Pharmacokinetic modeling of cisplatin disposition in children and adolescents with cancer.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6891625PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3691598

GET https://conductscience.org/api/papers/v1/3691598/authors